LENALIDOMIDE PLUS LOW DOSE DEXAMETHASONE AS FIRST LINE THERAPY IN PATIENTS WITH PRIMARY PLASMA CELL LEUKEMIA: PLANNED INTERIM ANALYSIS OF A PILOT STUDY FROM THE GIMEMA-ITALIAN MYELOMA NETWORK